Dr Camille Ettelaie C.Ettelaie@hull.ac.uk
Lecturer
Can prevention of the activation of PAR2 prevent the release of procoagulant microvesicles from cancer cells, reduce the risk of VTE and contain the deterioration of the vasculature?
People Involved
Professor Anthony Maraveyas A.Maraveyas@hull.ac.uk
Professor in Cancer Medicine
Project Description
The study aims to demonstrate the indirect effect of Apixaban on suppressing the release of pro-inflammatory, pro-coagulant tissue factor-containing microvesicles, by inhibiting factor Xa and preventing the activation of PAR2. The study also demonstrate the long-term beneficial influences through preventing the damage to the endothelial layer.
| Status | Project Complete |
|---|---|
| Value | £56,000.00 |
| Project Dates | Jul 1, 2015 - Jun 30, 2020 |
You might also like
A study of the incorporation and release of tissue factor as cancer cell-derived microparticles. Aug 1, 2014 - Jul 31, 2017
Differentiating the malignant potential of pancreatic cysts Oct 1, 2017 - Dec 31, 2022
The effective diagnosis of pancreatic cancer is often quite challenging, due to a lack of disease-specific symptoms, resulting in the majority of patients presenting with advanced disease, with an associated dismal prognosis. Earlier detection of pan...
Read More about Differentiating the malignant potential of pancreatic cysts.
Bridging grant for Research PhD student Nov 1, 2017 - Apr 18, 2018
The fund is to support the stipend and some of the fees incurred to bridge the funding for the PhD student.
Molecular pathways of pancreatic cancer carcinogenesis from pancreatic cystic neoplasms to adenocarcinoma Sep 1, 2020 - Aug 31, 2023
Pancreatic cancer is one of the main research areas of expertise of Professor Maraveyas and his team. This is an exciting opportunity to work on molecular pathways in pancreatic tissue that reflect the early changes during carcinogenesis and transla...
Read More about Molecular pathways of pancreatic cancer carcinogenesis from pancreatic cystic neoplasms to adenocarcinoma.